Method of treatment of a metabolic disease using intranasal administration of exendin peptide
Methods for treating metabolic diseases are described for intranasal delivery of an exenatide, comprising an aqueous mixture of exendin, and a delivery enhancer selected from the group consisting of a solubilizer, a chelator, and a surfactant, and the pharmaceutical formulations used therein.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
21.09.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Methods for treating metabolic diseases are described for intranasal delivery of an exenatide, comprising an aqueous mixture of exendin, and a delivery enhancer selected from the group consisting of a solubilizer, a chelator, and a surfactant, and the pharmaceutical formulations used therein. |
---|---|
AbstractList | Methods for treating metabolic diseases are described for intranasal delivery of an exenatide, comprising an aqueous mixture of exendin, and a delivery enhancer selected from the group consisting of a solubilizer, a chelator, and a surfactant, and the pharmaceutical formulations used therein. |
Author | LEONARD ALEXIS K QUAY STEVEN C COSTANTINO HENRY R |
Author_xml | – fullname: LEONARD ALEXIS K – fullname: QUAY STEVEN C – fullname: COSTANTINO HENRY R |
BookMark | eNqNi70KwkAQBq_Qwr93WLAWkijpRRQbK7WUsOa-6EKyd-RW8PE14ANYDQMzUzfSoJi42wn2DJ5CQ9aDrYPaIEwdjO-hlZq8JHACvZLog0StZ-XELbHvRCV93STosOEN9aIUEU085m7ccJuw-HHmlof9ZXdcIYYKKXINhVXXc5FlZZFnZb7Z5uv_qg9EKD8U |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US2006210614A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US2006210614A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 11:58:02 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US2006210614A13 |
Notes | Application Number: US20060418982 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060921&DB=EPODOC&CC=US&NR=2006210614A1 |
ParticipantIDs | epo_espacenet_US2006210614A1 |
PublicationCentury | 2000 |
PublicationDate | 20060921 |
PublicationDateYYYYMMDD | 2006-09-21 |
PublicationDate_xml | – month: 09 year: 2006 text: 20060921 day: 21 |
PublicationDecade | 2000 |
PublicationYear | 2006 |
RelatedCompanies | NASTECH PHARMACEUTICAL COMPANY INC |
RelatedCompanies_xml | – name: NASTECH PHARMACEUTICAL COMPANY INC |
Score | 2.648489 |
Snippet | Methods for treating metabolic diseases are described for intranasal delivery of an exenatide, comprising an aqueous mixture of exendin, and a delivery... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BANDAGES, DRESSINGS OR ABSORBENT PADS DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS FILTERS IMPLANTABLE INTO BLOOD VESSELS FIRST-AID KITS FOMENTATION HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROSTHESES TREATMENT OR PROTECTION OF EYES OR EARS |
Title | Method of treatment of a metabolic disease using intranasal administration of exendin peptide |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060921&DB=EPODOC&locale=&CC=US&NR=2006210614A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKeqbTsXLlIDSt6K9rG0eirheGEK34VbZi4y0SWUw22Er-vNNYlfny96SHBKSwMnJuX0H4DazudjRDKpmGCfCdGOphH88VIdZqWmZjBFZvi0aWoPYfJr1Zi1YrnNhJE7olwRH5ByVcn6v5Hu9-jNi-TK2srxLFnyoeAinrq802vE91jXF77vBeOSPPMXz3HiiDJ8lTZfqzyPXlXbER1og7QcvfZGXstoUKuEh7I75enl1BC2Wd2DfW9de68BeVLu8ebPmvvIYXiNZ7hkVGWriw0WHoHe-2UQg_KLa4YJEPPsbWgjTbU5KskTkH0qumMa-mUhpQSsR2ELZCdyEwdQbqHyf8-Za5vFk81DGKbTzImdngKzUTns0w5Q51CSEYlPLsE2owRLbIbZzDt1tK11sJ1_Cwa8ZAqu61oV29fHJrrhgrpJreZ8_HMWTjQ |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haMSbosYP1Caa3RbdB-t6WIxskKkMiAzDxZBu7QwJDiIz-ufbVkC8cGv70qZt8vr6vn4P4DrDQuwYFtMzQhJpunF0Kj4eusud1HZszqkq3xZ1nHBgPw7rwxJMlrkwCif0S4EjCo5KBb8X6r2e_RmxAhVbOb9JxmJoeteKvUBbace3xDS0oOE1e92g62u-7w36WudZ0Uyl_twLXWkLS3xe-Xl6aci8lNm6UGntwXZPrJcX-1DieRUq_rL2WhV2ooXLWzQX3Dc_gNdIlXtG0wyt4sNlh6J3sdlEIvyihcMFyXj2NzSWptuczukE0X8ouXIa_-YypQXNZGAL44dw1WrGfqiLfY5W1zIa9NcPZR1BOZ_m_BiQk-K0zjLCuMtsShmxjYxgyiyeYJdi9wRqm1Y63Uy-hEoYR-1R-6HzdAa7vyYJoptGDcrFxyc_F0K6SC7U3f4ALJ-Weg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Method+of+treatment+of+a+metabolic+disease+using+intranasal+administration+of+exendin+peptide&rft.inventor=LEONARD+ALEXIS+K&rft.inventor=QUAY+STEVEN+C&rft.inventor=COSTANTINO+HENRY+R&rft.date=2006-09-21&rft.externalDBID=A1&rft.externalDocID=US2006210614A1 |